Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bay G 2821
2. G 2821, Bay
1. 55294-15-0
2. Edrul
3. Muzolimina
4. Bay G 2821
5. Bay-g-2821
6. Bay-g 2821; Edrul
7. 3-amino-1-(1-(3,4-dichlorophenyl)ethyl)-1h-pyrazol-5(4h)-one
8. Bay-g 2821
9. 07z36289zx
10. Muzolimina [spanish]
11. 3h-pyrazol-3-one, 5-amino-2-(1-(3,4-dichlorophenyl)ethyl)-2,4-dihydro-
12. 3h-pyrazol-3-one, 5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-2,4-dihydro-
13. Muzoliminum
14. Muzoliminum [inn-latin]
15. Muzolimina [inn-spanish]
16. Einecs 259-573-2
17. Brn 0660881
18. Muzolimine [usan:inn:ban]
19. Unii-07z36289zx
20. 5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-4h-pyrazol-3-one
21. Muzolimine [mi]
22. 3-amino-1-(3,4-dichloro-alpha-methylbenzyl)-2-pyrazolin-5-one
23. Muzolimine [inn]
24. Muzolimine (usan/inn)
25. Muzolimine [usan]
26. 3-amino-1-(3,4-dichloro-alpha-methylbenzyl)-4,5-dihydro-5-pyrazolon
27. 3h-pyrazol-3-one, 2,4-dihydro-5-amino-2-(1-(3,4-dichlorophenyl)ethyl)-
28. 5-amino-2-(1-(3,4-dichlorophenyl)-ethyl)-2,4-dihydro-3h-pyrazol-3-one
29. Muzolimine [mart.]
30. Muzolimine [who-dd]
31. Schembl123392
32. Chembl1697760
33. Dtxsid50866476
34. Chebi:135124
35. 5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-2,4-dihydro-3h-pyrazol-3-one
36. Db13801
37. Da-04927
38. Hy-106616
39. Cs-0026158
40. Ft-0759718
41. D05093
42. Q3868794
43. 3-amino-1-(3,4-dichloro-a-methylbenzyl)-2-pyrazolin-5-one
44. 3-amino-1-(3,4-dichloro-.alpha.-methylbenzyl)-2-pyrazolin-5-one
Molecular Weight | 272.13 g/mol |
---|---|
Molecular Formula | C11H11Cl2N3O |
XLogP3 | 2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 271.0279174 g/mol |
Monoisotopic Mass | 271.0279174 g/mol |
Topological Polar Surface Area | 58.7 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 348 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Diuretics
Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)
C - Cardiovascular system
C03 - Diuretics
C03C - High-ceiling diuretics
C03CD - Pyrazolone derivatives
C03CD01 - Muzolimine
ABOUT THIS PAGE
A Muzolimine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Muzolimine, including repackagers and relabelers. The FDA regulates Muzolimine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Muzolimine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Muzolimine supplier is an individual or a company that provides Muzolimine active pharmaceutical ingredient (API) or Muzolimine finished formulations upon request. The Muzolimine suppliers may include Muzolimine API manufacturers, exporters, distributors and traders.
click here to find a list of Muzolimine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Muzolimine DMF (Drug Master File) is a document detailing the whole manufacturing process of Muzolimine active pharmaceutical ingredient (API) in detail. Different forms of Muzolimine DMFs exist exist since differing nations have different regulations, such as Muzolimine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Muzolimine DMF submitted to regulatory agencies in the US is known as a USDMF. Muzolimine USDMF includes data on Muzolimine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Muzolimine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Muzolimine suppliers with USDMF on PharmaCompass.
Muzolimine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Muzolimine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Muzolimine GMP manufacturer or Muzolimine GMP API supplier for your needs.
A Muzolimine CoA (Certificate of Analysis) is a formal document that attests to Muzolimine's compliance with Muzolimine specifications and serves as a tool for batch-level quality control.
Muzolimine CoA mostly includes findings from lab analyses of a specific batch. For each Muzolimine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Muzolimine may be tested according to a variety of international standards, such as European Pharmacopoeia (Muzolimine EP), Muzolimine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Muzolimine USP).
LOOKING FOR A SUPPLIER?